Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Frits Van Rhee

Concepts (569)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Multiple Myeloma
152
2024
3049
10.980
 Why?
Antibodies, Monoclonal
26
2024
564
6.270
 Why?
Antineoplastic Agents
18
2024
1300
3.360
 Why?
Antineoplastic Combined Chemotherapy Protocols
41
2024
1060
3.280
 Why?
Hematopoietic Stem Cell Transplantation
26
2024
583
2.870
 Why?
Humans
201
2024
54304
2.090
 Why?
Monoclonal Gammopathy of Undetermined Significance
9
2023
108
1.960
 Why?
Neoplasm Recurrence, Local
15
2024
645
1.930
 Why?
Thalidomide
23
2019
398
1.920
 Why?
Killer Cells, Natural
7
2020
106
1.810
 Why?
Immunotherapy, Adoptive
8
2024
134
1.770
 Why?
Interleukin-6
12
2023
315
1.740
 Why?
Hematologic Neoplasms
3
2022
100
1.680
 Why?
Neoplasm Proteins
13
2022
360
1.650
 Why?
Antigens, Neoplasm
6
2014
170
1.520
 Why?
Clinical Trials as Topic
13
2022
490
1.490
 Why?
Stem Cell Transplantation
10
2022
201
1.430
 Why?
Middle Aged
67
2022
13076
1.350
 Why?
Gene Expression Regulation, Neoplastic
20
2022
868
1.320
 Why?
Prognosis
44
2024
2126
1.320
 Why?
Combined Modality Therapy
19
2024
693
1.310
 Why?
Chromosomes, Human, Pair 1
9
2023
113
1.310
 Why?
Herpesvirus 8, Human
7
2021
90
1.300
 Why?
Translocation, Genetic
10
2022
287
1.230
 Why?
Boronic Acids
12
2013
197
1.170
 Why?
Pyrazines
12
2013
203
1.170
 Why?
Treatment Outcome
46
2022
5609
1.120
 Why?
Aged
67
2021
10054
1.120
 Why?
Bone Marrow
18
2024
414
1.100
 Why?
Immunotherapy
6
2024
264
1.030
 Why?
Gene Expression Profiling
26
2023
1141
1.010
 Why?
Disease-Free Survival
24
2019
488
0.990
 Why?
Female
78
2021
28457
0.980
 Why?
Adult
47
2022
14189
0.980
 Why?
Male
75
2022
27335
0.970
 Why?
Transplantation, Autologous
24
2024
485
0.960
 Why?
T-Lymphocytes, Cytotoxic
4
2014
72
0.940
 Why?
Melphalan
9
2020
184
0.930
 Why?
B-Lymphocytes
4
2022
176
0.920
 Why?
Cancer Vaccines
3
2010
103
0.890
 Why?
Follow-Up Studies
26
2024
2389
0.890
 Why?
Hyperhidrosis
1
2022
3
0.880
 Why?
Plasma Cells
11
2023
239
0.880
 Why?
Sweat
1
2022
7
0.880
 Why?
Proteasome Inhibitors
4
2018
111
0.880
 Why?
Antibodies, Bispecific
4
2024
43
0.870
 Why?
Survival Rate
24
2020
954
0.840
 Why?
Lymphoma, B-Cell
3
2022
62
0.840
 Why?
Drug Approval
1
2022
47
0.830
 Why?
Ehrlichia chaffeensis
1
2021
8
0.800
 Why?
Patient Participation
1
2022
68
0.800
 Why?
Cryosurgery
1
2021
38
0.790
 Why?
Ehrlichiosis
1
2021
20
0.790
 Why?
Immunoglobulin Light Chains
3
2017
101
0.770
 Why?
T-Lymphocytes
8
2024
374
0.770
 Why?
Lymphohistiocytosis, Hemophagocytic
1
2021
30
0.770
 Why?
Dexamethasone
13
2024
435
0.760
 Why?
B-Cell Maturation Antigen
6
2024
72
0.750
 Why?
Embolization, Therapeutic
1
2021
98
0.730
 Why?
Cell Proliferation
10
2023
1097
0.710
 Why?
Disease Progression
16
2023
915
0.710
 Why?
Chromosomal Instability
1
2019
17
0.710
 Why?
Neoplasms, Plasma Cell
3
2024
39
0.690
 Why?
Adrenal Cortex Hormones
2
2023
95
0.680
 Why?
Membrane Proteins
3
2006
389
0.670
 Why?
Immunologic Factors
2
2018
130
0.650
 Why?
Neoplasm, Residual
8
2022
167
0.650
 Why?
Epigenesis, Genetic
4
2023
399
0.650
 Why?
POEMS Syndrome
1
2018
32
0.630
 Why?
Chromosome Aberrations
12
2023
316
0.630
 Why?
Dendritic Cells
3
2014
142
0.630
 Why?
Atrial Fibrillation
2
2022
197
0.610
 Why?
Survival Analysis
17
2023
736
0.610
 Why?
Prealbumin
2
2014
24
0.600
 Why?
Thyroid Neoplasms
1
2019
162
0.580
 Why?
Antibodies, Monoclonal, Humanized
6
2023
240
0.580
 Why?
Receptors, Interleukin-6
2
2014
29
0.580
 Why?
Positron-Emission Tomography
7
2022
323
0.570
 Why?
Cardiomyopathies
2
2014
131
0.540
 Why?
Osteolysis
4
2022
87
0.510
 Why?
Mutation
10
2022
1504
0.500
 Why?
Immunotoxins
1
2014
5
0.500
 Why?
Cytotoxicity, Immunologic
2
2012
62
0.490
 Why?
Clonal Evolution
3
2020
60
0.480
 Why?
Practice Guidelines as Topic
4
2023
487
0.460
 Why?
Cyclophosphamide
5
2021
172
0.460
 Why?
Transplantation, Homologous
5
2017
154
0.450
 Why?
Amyloidosis
1
2014
85
0.450
 Why?
Tumor Microenvironment
5
2023
210
0.440
 Why?
Aged, 80 and over
17
2021
3430
0.440
 Why?
Health Status
1
2015
368
0.430
 Why?
Remission Induction
13
2021
222
0.420
 Why?
Fluorodeoxyglucose F18
6
2021
212
0.420
 Why?
Neutropenia
2
2023
120
0.420
 Why?
Receptors, KIR
2
2008
15
0.410
 Why?
Risk Factors
18
2021
3934
0.410
 Why?
Polymorphism, Single Nucleotide
2
2020
552
0.390
 Why?
Pyrimidines
2
2022
196
0.390
 Why?
Bone Diseases
3
2021
108
0.390
 Why?
Azacitidine
1
2010
37
0.390
 Why?
Thrombocytopenia
2
2022
99
0.380
 Why?
Dose-Response Relationship, Drug
8
2020
1476
0.380
 Why?
Benzamides
1
2010
54
0.380
 Why?
Evolution, Molecular
2
2021
103
0.380
 Why?
Recurrence
11
2021
692
0.370
 Why?
Histone Deacetylase Inhibitors
1
2010
56
0.370
 Why?
C-Reactive Protein
6
2022
159
0.360
 Why?
Prednisone
2
2021
111
0.360
 Why?
Doxorubicin
6
2021
259
0.360
 Why?
TOR Serine-Threonine Kinases
2
2020
85
0.350
 Why?
Drug Administration Schedule
5
2015
401
0.350
 Why?
Chromosome Deletion
5
2023
150
0.340
 Why?
Metaphase
4
2016
55
0.340
 Why?
Vaccination
4
2022
298
0.340
 Why?
Pelvis
2
2021
77
0.340
 Why?
Membrane Glycoproteins
2
2009
270
0.330
 Why?
Quality of Life
1
2015
922
0.330
 Why?
Paraproteinemias
3
2022
80
0.330
 Why?
Proportional Hazards Models
7
2024
430
0.320
 Why?
Placebo Effect
2
2020
19
0.320
 Why?
Bone Neoplasms
4
2013
193
0.320
 Why?
Adoptive Transfer
1
2007
38
0.310
 Why?
Histocompatibility Antigens Class I
1
2007
52
0.310
 Why?
Chromatin
3
2023
156
0.300
 Why?
Cytogenetic Analysis
5
2023
90
0.300
 Why?
DNA Methylation
4
2023
575
0.290
 Why?
Animals
14
2024
14402
0.290
 Why?
Drug Resistance, Neoplasm
6
2021
309
0.290
 Why?
Vincristine
3
2021
98
0.290
 Why?
Mice, SCID
6
2013
196
0.290
 Why?
Risk Assessment
9
2022
1361
0.280
 Why?
Cell Membrane
1
2007
279
0.280
 Why?
In Situ Hybridization, Fluorescence
5
2023
278
0.280
 Why?
Down-Regulation
1
2007
388
0.280
 Why?
Angiogenesis Inhibitors
5
2010
203
0.280
 Why?
Neoplasm Staging
6
2024
805
0.270
 Why?
Chromosomes, Human, Pair 17
2
2017
43
0.270
 Why?
Transplantation Conditioning
5
2008
87
0.270
 Why?
Disease Management
2
2018
184
0.270
 Why?
Cell Line, Tumor
9
2023
1551
0.260
 Why?
Infusions, Intravenous
3
2015
231
0.260
 Why?
Bone Resorption
2
2022
328
0.260
 Why?
Antibody Formation
1
2005
69
0.250
 Why?
Fever
2
2022
129
0.250
 Why?
Polycomb Repressive Complex 2
2
2021
50
0.250
 Why?
CD8-Positive T-Lymphocytes
2
2020
116
0.250
 Why?
Pentaerythritol Tetranitrate
1
2024
6
0.240
 Why?
Monocytes
2
2020
156
0.240
 Why?
Flow Cytometry
4
2012
547
0.240
 Why?
Time Factors
11
2021
3207
0.230
 Why?
Gene Expression
2
2018
664
0.230
 Why?
High-Throughput Nucleotide Sequencing
3
2022
206
0.230
 Why?
Epstein-Barr Virus Infections
2
2020
35
0.230
 Why?
Proteasome Endopeptidase Complex
3
2011
131
0.230
 Why?
Cell Cycle Proteins
2
2022
198
0.230
 Why?
Chromans
1
2024
62
0.230
 Why?
Integrin beta Chains
1
2023
14
0.230
 Why?
Blotting, Western
3
2015
684
0.230
 Why?
Mice
10
2024
6428
0.230
 Why?
Integrins
1
2023
36
0.230
 Why?
Signal Transduction
6
2021
1751
0.220
 Why?
Prospective Studies
8
2022
2604
0.220
 Why?
Double-Blind Method
2
2015
742
0.220
 Why?
Sweating
1
2022
19
0.220
 Why?
Cross-Sectional Studies
3
2023
1693
0.220
 Why?
Young Adult
5
2020
4313
0.220
 Why?
Consensus
2
2020
156
0.210
 Why?
Radiation-Protective Agents
1
2024
116
0.210
 Why?
Case-Control Studies
5
2019
1229
0.210
 Why?
DNA, Intergenic
1
2022
6
0.210
 Why?
Proto-Oncogene Proteins B-raf
2
2020
92
0.210
 Why?
Immunoconjugates
1
2022
38
0.210
 Why?
Receptors, Antigen, T-Cell
1
2022
50
0.210
 Why?
Tumor Cells, Cultured
4
2013
477
0.210
 Why?
Kaplan-Meier Estimate
10
2016
514
0.210
 Why?
Tumor Suppressor Protein p53
2
2017
251
0.210
 Why?
Waldenstrom Macroglobulinemia
1
2022
41
0.210
 Why?
United States Food and Drug Administration
1
2022
97
0.210
 Why?
Proteomics
3
2021
343
0.210
 Why?
Epigenomics
1
2021
67
0.200
 Why?
Mediastinum
1
2021
27
0.200
 Why?
Chromosomes, Human, Pair 14
3
2020
76
0.200
 Why?
Receptors, Glucocorticoid
2
2012
36
0.200
 Why?
United States
4
2022
5204
0.200
 Why?
Registries
2
2022
552
0.200
 Why?
Ubiquitination
1
2021
47
0.200
 Why?
Influenza, Human
1
2022
120
0.200
 Why?
Phosphatidylinositol 3-Kinases
2
2019
153
0.200
 Why?
Axilla
1
2021
101
0.200
 Why?
Genetic Predisposition to Disease
2
2022
571
0.200
 Why?
Multiple Organ Failure
1
2021
56
0.200
 Why?
Alleles
3
2021
277
0.190
 Why?
Salvage Therapy
6
2013
145
0.190
 Why?
Proto-Oncogene Proteins c-maf
2
2020
20
0.190
 Why?
Epstein-Barr Virus Nuclear Antigens
1
2020
1
0.190
 Why?
Diffusion Magnetic Resonance Imaging
2
2019
128
0.190
 Why?
Lymphoma, Large B-Cell, Diffuse
1
2022
106
0.190
 Why?
Rare Diseases
1
2020
46
0.190
 Why?
Genome-Wide Association Study
2
2020
190
0.190
 Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
2022
105
0.190
 Why?
Interferon-gamma
3
2014
195
0.190
 Why?
Apoptosis
5
2018
1302
0.190
 Why?
Genes, Tumor Suppressor
2
2021
85
0.190
 Why?
Exosome Multienzyme Ribonuclease Complex
1
2020
14
0.180
 Why?
Leukemia, Plasma Cell
1
2020
34
0.180
 Why?
Myelodysplastic Syndromes
2
2013
79
0.180
 Why?
Interferon Type I
1
2020
30
0.180
 Why?
Research Design
2
2020
356
0.180
 Why?
Cytokines
2
2014
677
0.180
 Why?
Cell Cycle
1
2021
275
0.180
 Why?
Radiopharmaceuticals
4
2021
242
0.180
 Why?
Gene Amplification
1
2019
57
0.180
 Why?
Measles virus
1
2019
9
0.180
 Why?
Multivariate Analysis
8
2021
643
0.180
 Why?
Hematopoiesis, Extramedullary
1
2019
10
0.180
 Why?
Measles
1
2019
9
0.180
 Why?
Genomics
4
2023
313
0.180
 Why?
Gene Regulatory Networks
1
2020
124
0.180
 Why?
Oncolytic Virotherapy
1
2019
18
0.170
 Why?
Health Status Disparities
1
2022
219
0.170
 Why?
Data Collection
1
2020
319
0.170
 Why?
Immunohistochemistry
2
2015
1090
0.170
 Why?
DNA
1
2023
581
0.170
 Why?
Sirolimus
1
2019
65
0.170
 Why?
Patient Safety
1
2020
121
0.170
 Why?
Healthcare Disparities
1
2022
270
0.170
 Why?
Insulin-Like Growth Factor Binding Protein 2
1
2018
11
0.170
 Why?
Biopsy
5
2018
693
0.170
 Why?
Syndrome
1
2019
253
0.170
 Why?
Precancerous Conditions
2
2010
93
0.170
 Why?
Proto-Oncogene Proteins c-akt
1
2019
176
0.170
 Why?
Evidence-Based Medicine
2
2018
275
0.170
 Why?
Graft vs Host Disease
4
2007
84
0.170
 Why?
Cell Differentiation
6
2022
720
0.160
 Why?
MafB Transcription Factor
1
2018
11
0.160
 Why?
Spleen
1
2019
187
0.160
 Why?
Genomic Instability
2
2016
95
0.160
 Why?
Phosphotransferases
1
2018
24
0.160
 Why?
Immunomodulation
1
2018
42
0.160
 Why?
Plasma
1
2018
52
0.160
 Why?
Myeloablative Agonists
2
2008
33
0.160
 Why?
Chemokines
1
2018
96
0.160
 Why?
Hematopoietic Stem Cell Mobilization
2
2008
61
0.160
 Why?
Genes, Neoplasm
2
2015
36
0.160
 Why?
Adipocytes
1
2018
128
0.150
 Why?
Osteoclasts
3
2022
469
0.150
 Why?
Gene Rearrangement
1
2018
76
0.150
 Why?
Gene Dosage
2
2015
92
0.150
 Why?
Magnetic Resonance Imaging
5
2013
1616
0.150
 Why?
Hexokinase
1
2017
18
0.150
 Why?
Communication
1
2019
265
0.150
 Why?
Heterozygote
2
2014
96
0.150
 Why?
HLA-A Antigens
2
2007
13
0.150
 Why?
Calcification, Physiologic
1
2017
42
0.150
 Why?
Models, Biological
2
2018
825
0.150
 Why?
Protein-Tyrosine Kinases
2
2018
101
0.150
 Why?
Drug Therapy, Combination
1
2018
426
0.140
 Why?
Gene Frequency
2
2013
120
0.140
 Why?
Oligonucleotide Array Sequence Analysis
5
2010
474
0.140
 Why?
Syndecan-1
4
2021
82
0.140
 Why?
Transcriptome
4
2020
346
0.140
 Why?
Confidence Intervals
2
2014
166
0.140
 Why?
Lymphocyte Activation
2
2017
197
0.140
 Why?
Tumor Burden
3
2020
141
0.140
 Why?
Immunity, Innate
1
2016
114
0.130
 Why?
Erythrocyte Indices
1
2015
8
0.130
 Why?
Biomarkers, Pharmacological
2
2012
28
0.130
 Why?
Gene Expression Regulation, Enzymologic
1
2017
205
0.130
 Why?
DNA Copy Number Variations
3
2022
114
0.130
 Why?
Longitudinal Studies
4
2023
742
0.130
 Why?
Adolescent
5
2020
6896
0.130
 Why?
Critical Illness
1
2018
343
0.130
 Why?
Coculture Techniques
2
2013
159
0.130
 Why?
Hemoglobins
2
2013
126
0.130
 Why?
Cysteine-Rich Protein 61
1
2014
4
0.130
 Why?
Hematologic Diseases
1
2014
25
0.120
 Why?
Half-Life
1
2014
92
0.120
 Why?
International Cooperation
1
2014
62
0.120
 Why?
Fatigue
1
2015
128
0.120
 Why?
Area Under Curve
1
2014
205
0.120
 Why?
Enzyme-Linked Immunosorbent Assay
1
2015
314
0.120
 Why?
Amyloid Neuropathies, Familial
1
2013
5
0.120
 Why?
Iron
1
2015
157
0.120
 Why?
ROC Curve
1
2014
259
0.120
 Why?
Antineoplastic Agents, Alkylating
3
2008
74
0.120
 Why?
Antibodies
2
2024
178
0.120
 Why?
Reference Values
1
2014
353
0.120
 Why?
Emotions
1
2015
170
0.120
 Why?
Administration, Metronomic
1
2013
7
0.120
 Why?
Neoplasms, Glandular and Epithelial
1
2014
48
0.120
 Why?
Cystatin M
2
2024
21
0.120
 Why?
Renal Insufficiency
2
2021
138
0.110
 Why?
Nicotinamide Phosphoribosyltransferase
1
2013
6
0.110
 Why?
Central Nervous System Neoplasms
1
2013
57
0.110
 Why?
Severity of Illness Index
2
2014
1083
0.110
 Why?
Inflammation Mediators
1
2014
128
0.110
 Why?
Retrospective Studies
7
2024
6462
0.110
 Why?
beta Catenin
1
2013
102
0.110
 Why?
Disease Models, Animal
2
2016
1651
0.110
 Why?
Oligopeptides
1
2013
95
0.110
 Why?
Antibody-Dependent Cell Cytotoxicity
2
2009
15
0.110
 Why?
Cisplatin
4
2013
351
0.110
 Why?
Myelolipoma
1
2012
10
0.110
 Why?
Leukemia
1
2013
69
0.110
 Why?
Lymph Nodes
3
2021
284
0.110
 Why?
Venous Thrombosis
2
2004
102
0.110
 Why?
Mental Health
1
2015
244
0.110
 Why?
Interleukin Receptor Common gamma Subunit
1
2012
10
0.110
 Why?
NK Cell Lectin-Like Receptor Subfamily K
1
2012
11
0.110
 Why?
Maintenance Chemotherapy
1
2012
48
0.110
 Why?
Clone Cells
2
2023
89
0.110
 Why?
Cell Survival
2
2020
657
0.110
 Why?
Interleukin-2
1
2012
75
0.100
 Why?
Mice, Inbred NOD
1
2012
99
0.100
 Why?
Cell Movement
1
2013
271
0.100
 Why?
Immunoenzyme Techniques
1
2012
166
0.100
 Why?
Vascular Endothelial Growth Factor A
1
2013
233
0.100
 Why?
Pain
1
2015
404
0.100
 Why?
Hemangioma
1
2013
83
0.100
 Why?
Models, Genetic
2
2016
208
0.100
 Why?
Neoplasms, Second Primary
1
2012
77
0.100
 Why?
Soft Tissue Neoplasms
1
2012
65
0.100
 Why?
Genotype
1
2013
600
0.100
 Why?
Arkansas
5
2021
2097
0.100
 Why?
Transduction, Genetic
2
2014
50
0.100
 Why?
Chemokine CXCL13
2
2022
4
0.100
 Why?
Transcriptional Elongation Factors
2
2022
28
0.100
 Why?
Peripheral Blood Stem Cell Transplantation
2
2008
57
0.100
 Why?
Mutation Rate
2
2021
40
0.100
 Why?
CD40 Ligand
1
2010
15
0.100
 Why?
Immunoglobulin Idiotypes
1
2010
18
0.100
 Why?
Hypersensitivity, Delayed
1
2010
21
0.100
 Why?
Models, Statistical
2
2014
258
0.090
 Why?
Interleukin-4
1
2010
48
0.090
 Why?
Secondary Prevention
1
2010
89
0.090
 Why?
HIV Seropositivity
1
2010
28
0.090
 Why?
Eukaryotic Initiation Factor-2
1
2010
18
0.090
 Why?
Immunity, Cellular
1
2010
80
0.090
 Why?
Adjuvants, Immunologic
1
2010
61
0.090
 Why?
Up-Regulation
4
2018
509
0.090
 Why?
Etoposide
2
2007
86
0.090
 Why?
Transplantation, Heterologous
1
2009
76
0.090
 Why?
Cell Line
2
2013
1152
0.090
 Why?
Cells, Cultured
3
2013
1737
0.090
 Why?
Placenta
1
2011
136
0.090
 Why?
Ovarian Neoplasms
1
2014
474
0.090
 Why?
Cytotoxicity Tests, Immunologic
1
2008
31
0.080
 Why?
Radiography
4
2012
526
0.080
 Why?
Histones
2
2021
335
0.080
 Why?
Polymerase Chain Reaction
1
2010
531
0.080
 Why?
Lymphocyte Subsets
1
2008
13
0.080
 Why?
Immunoglobulin lambda-Chains
1
2008
18
0.080
 Why?
Granulocyte Colony-Stimulating Factor
1
2008
69
0.080
 Why?
Cytogenetics
1
2008
28
0.080
 Why?
Bone and Bones
3
2021
515
0.080
 Why?
Haplotypes
1
2008
105
0.080
 Why?
Receptors, Immunologic
1
2008
37
0.080
 Why?
Transcription Factors
2
2023
622
0.080
 Why?
Liver Neoplasms
1
2012
352
0.080
 Why?
Gene Deletion
1
2009
293
0.080
 Why?
Neoplastic Stem Cells
1
2009
104
0.080
 Why?
Ligands
1
2008
229
0.080
 Why?
Osteogenesis
1
2011
377
0.080
 Why?
Twins
1
2007
32
0.080
 Why?
Busulfan
1
2007
19
0.080
 Why?
Herpesviridae Infections
2
2019
46
0.080
 Why?
Immunophenotyping
1
2007
117
0.080
 Why?
Diphosphonates
1
2008
96
0.080
 Why?
Leukocytes, Mononuclear
1
2007
133
0.070
 Why?
Antimetabolites
1
2006
12
0.070
 Why?
Caspases
2
2018
146
0.070
 Why?
Creatinine
1
2007
169
0.070
 Why?
Blood Proteins
1
2007
100
0.070
 Why?
Antibodies, Neoplasm
1
2006
35
0.070
 Why?
Graft vs Leukemia Effect
1
2006
2
0.070
 Why?
Chromosome Banding
1
2006
28
0.070
 Why?
Immunosuppressive Agents
1
2008
248
0.070
 Why?
Plasmacytoma
1
2006
47
0.070
 Why?
Skin Neoplasms
1
2012
532
0.070
 Why?
HLA-A2 Antigen
1
2005
12
0.070
 Why?
Amiloride
1
2005
14
0.070
 Why?
Cohort Studies
3
2020
1547
0.070
 Why?
MicroRNAs
1
2010
386
0.070
 Why?
Bone Marrow Transplantation
2
2022
149
0.070
 Why?
Imaging, Three-Dimensional
2
2017
172
0.070
 Why?
Poly(ADP-ribose) Polymerases
2
2016
43
0.060
 Why?
Sensitivity and Specificity
1
2007
922
0.060
 Why?
Tomography, X-Ray Computed
2
2023
1222
0.060
 Why?
Predictive Value of Tests
3
2018
1044
0.060
 Why?
Enoxaparin
1
2004
25
0.060
 Why?
Ferritins
1
2024
31
0.060
 Why?
Myeloid Progenitor Cells
1
2023
19
0.060
 Why?
X-Ray Microtomography
1
2024
81
0.060
 Why?
Macaca mulatta
1
2024
106
0.060
 Why?
Receptors, G-Protein-Coupled
1
2024
55
0.060
 Why?
NF-kappa B
2
2018
336
0.060
 Why?
Epidemiologic Methods
3
2008
49
0.060
 Why?
Gene Silencing
2
2016
129
0.060
 Why?
DNA, Neoplasm
2
2020
171
0.060
 Why?
Fibroblasts
1
2005
386
0.060
 Why?
Neoplasms
1
2014
1321
0.060
 Why?
Cell Communication
1
2023
72
0.060
 Why?
Cluster Analysis
3
2010
244
0.060
 Why?
TNF Receptor-Associated Factor 3
1
2022
14
0.060
 Why?
Vitamin E
1
2024
107
0.050
 Why?
Patients
1
2022
53
0.050
 Why?
Geography
1
2022
80
0.050
 Why?
Guanine Nucleotide Exchange Factors
1
2022
17
0.050
 Why?
Myeloid Differentiation Factor 88
1
2022
40
0.050
 Why?
Inheritance Patterns
1
2022
27
0.050
 Why?
Quantitative Trait Loci
1
2022
52
0.050
 Why?
Primary Cell Culture
1
2022
65
0.050
 Why?
Oncogenes
1
2021
63
0.050
 Why?
Chromosomal Proteins, Non-Histone
1
2022
44
0.050
 Why?
Risk
2
2014
343
0.050
 Why?
Patient Selection
1
2023
284
0.050
 Why?
Age of Onset
2
2013
117
0.050
 Why?
Anticoagulants
1
2004
270
0.050
 Why?
Phylogeny
1
2022
269
0.050
 Why?
RANK Ligand
1
2022
183
0.050
 Why?
Boron Compounds
1
2021
18
0.050
 Why?
SOXC Transcription Factors
1
2021
14
0.050
 Why?
Child, Preschool
2
2020
4161
0.050
 Why?
Polymorphism, Genetic
1
2022
193
0.050
 Why?
Transcriptional Activation
1
2021
134
0.050
 Why?
Rabbits
2
2013
425
0.050
 Why?
Adaptor Proteins, Signal Transducing
1
2022
208
0.050
 Why?
Proto-Oncogene Proteins p21(ras)
1
2021
70
0.050
 Why?
Glycine
1
2021
70
0.050
 Why?
Cyclin D2
1
2020
20
0.050
 Why?
Spatio-Temporal Analysis
1
2020
10
0.050
 Why?
Aneuploidy
1
2020
23
0.050
 Why?
Edema
1
2021
74
0.050
 Why?
Fibrosis
1
2021
209
0.050
 Why?
Chromosomes, Human, Pair 4
1
2020
30
0.050
 Why?
Gene Expression Regulation, Leukemic
1
2020
36
0.050
 Why?
Histone Code
1
2020
32
0.050
 Why?
Cyclin D1
1
2020
60
0.050
 Why?
Chromosomes, Human, Pair 11
1
2020
54
0.050
 Why?
Base Sequence
1
2022
719
0.050
 Why?
ras Proteins
1
2020
70
0.050
 Why?
Repressor Proteins
1
2022
165
0.050
 Why?
Protein Kinase Inhibitors
1
2022
216
0.050
 Why?
Genome, Human
1
2021
131
0.050
 Why?
Single-Cell Analysis
1
2020
56
0.050
 Why?
Genetic Loci
1
2020
58
0.040
 Why?
False Negative Reactions
1
2019
36
0.040
 Why?
Herpesvirus 4, Human
1
2019
39
0.040
 Why?
Neoplasm Invasiveness
1
2020
294
0.040
 Why?
DNA Mutational Analysis
1
2020
217
0.040
 Why?
Mice, Transgenic
1
2021
658
0.040
 Why?
Europe
1
2019
102
0.040
 Why?
Incidence
2
2013
1083
0.040
 Why?
Genetic Variation
1
2020
253
0.040
 Why?
Communicable Disease Control
1
2019
39
0.040
 Why?
beta 2-Microglobulin
2
2009
35
0.040
 Why?
Virus Diseases
1
2019
43
0.040
 Why?
Genome, Viral
1
2019
100
0.040
 Why?
Computational Biology
1
2020
231
0.040
 Why?
DNA, Viral
1
2019
143
0.040
 Why?
Fibrinogen
1
2018
37
0.040
 Why?
Glycogen Synthase Kinase 3
1
2018
21
0.040
 Why?
Immunoglobulin A
1
2018
54
0.040
 Why?
RNA, Messenger
2
2016
1203
0.040
 Why?
Platelet Count
2
2008
77
0.040
 Why?
Bone Marrow Cells
2
2014
232
0.040
 Why?
Hospitalization
1
2022
702
0.040
 Why?
Pathology, Molecular
1
2018
24
0.040
 Why?
Receptor Protein-Tyrosine Kinases
1
2018
52
0.040
 Why?
Oncogene Proteins, Fusion
1
2018
60
0.040
 Why?
DNA-Binding Proteins
1
2021
462
0.040
 Why?
Databases, Factual
2
2013
683
0.040
 Why?
Immunoglobulin G
1
2018
227
0.040
 Why?
Data Interpretation, Statistical
2
2010
173
0.040
 Why?
Promoter Regions, Genetic
1
2020
520
0.040
 Why?
Kidney Function Tests
1
2017
59
0.040
 Why?
False Positive Reactions
1
2017
68
0.040
 Why?
Child
2
2020
7372
0.040
 Why?
Lamins
1
2016
6
0.040
 Why?
Chromosomes, Human, Pair 16
1
2016
20
0.040
 Why?
Glomerular Filtration Rate
1
2017
139
0.040
 Why?
Internationality
1
2017
49
0.040
 Why?
Cell Transformation, Neoplastic
1
2018
200
0.040
 Why?
Alkaline Phosphatase
1
2017
99
0.040
 Why?
Genes, ras
1
2016
48
0.040
 Why?
Lymphocytes, Tumor-Infiltrating
1
2017
74
0.040
 Why?
Genes, p53
1
2016
60
0.040
 Why?
Amino Acid Sequence
1
2018
766
0.040
 Why?
Glycolysis
1
2016
73
0.040
 Why?
Proteolysis
1
2016
102
0.030
 Why?
Chromosome Mapping
2
2006
175
0.030
 Why?
Enzyme Activation
1
2016
328
0.030
 Why?
Prevalence
1
2019
1026
0.030
 Why?
Image Interpretation, Computer-Assisted
1
2016
119
0.030
 Why?
Phosphorylation
1
2016
613
0.030
 Why?
Gene Fusion
1
2014
14
0.030
 Why?
Asymptomatic Diseases
1
2014
43
0.030
 Why?
Interspersed Repetitive Sequences
1
2014
10
0.030
 Why?
Karyotype
1
2014
19
0.030
 Why?
Capsid
1
2014
3
0.030
 Why?
Lymphocyte Culture Test, Mixed
1
2014
8
0.030
 Why?
Myocardium
1
2017
443
0.030
 Why?
Kidney Diseases
1
2017
293
0.030
 Why?
HIV-1
1
2014
72
0.030
 Why?
Homozygote
1
2013
60
0.030
 Why?
Cerebrospinal Fluid
1
2013
36
0.030
 Why?
Nicotinamide Mononucleotide
1
2013
4
0.030
 Why?
Genetic Vectors
1
2014
139
0.030
 Why?
Acrylamides
1
2013
8
0.030
 Why?
Receptors, CXCR4
1
2013
31
0.030
 Why?
Chemokine CXCL12
1
2013
31
0.030
 Why?
NAD
1
2013
46
0.030
 Why?
Niacinamide
1
2013
25
0.030
 Why?
Dependovirus
1
2014
102
0.030
 Why?
Enzyme Induction
1
2013
80
0.030
 Why?
Sirtuin 1
1
2013
29
0.030
 Why?
Amides
1
2013
43
0.030
 Why?
Diagnosis, Differential
1
2017
1143
0.030
 Why?
Transplantation Chimera
2
2003
15
0.030
 Why?
Gene Knockdown Techniques
1
2013
125
0.030
 Why?
Nitriles
1
2013
69
0.030
 Why?
RNA, Small Interfering
1
2013
253
0.030
 Why?
Piperidines
1
2013
103
0.030
 Why?
Induction Chemotherapy
1
2012
59
0.030
 Why?
Lymphocyte Count
1
2011
23
0.030
 Why?
Chemokine CXCL10
1
2011
20
0.030
 Why?
Acute Disease
1
2013
403
0.030
 Why?
Infant
1
2020
3832
0.030
 Why?
HIV Infections
1
2016
394
0.030
 Why?
Antibodies, Neutralizing
1
2011
76
0.030
 Why?
Pharmacogenetics
1
2011
55
0.020
 Why?
Sex Factors
1
2013
766
0.020
 Why?
Clinical Trials, Phase I as Topic
1
2010
30
0.020
 Why?
Clinical Trials, Phase III as Topic
1
2010
48
0.020
 Why?
Clinical Trials, Phase II as Topic
1
2010
51
0.020
 Why?
Microarray Analysis
1
2010
85
0.020
 Why?
International Classification of Diseases
1
2010
65
0.020
 Why?
Argonaute Proteins
1
2010
11
0.020
 Why?
Enzyme Inhibitors
1
2013
445
0.020
 Why?
RNA-Binding Proteins
1
2011
136
0.020
 Why?
Oligonucleotides
1
2010
76
0.020
 Why?
Polyploidy
1
2009
11
0.020
 Why?
Bone Marrow Examination
1
2009
12
0.020
 Why?
L-Lactate Dehydrogenase
1
2009
79
0.020
 Why?
Hematopoietic Stem Cells
1
2011
215
0.020
 Why?
Ploidies
1
2008
13
0.020
 Why?
Neoplasm Metastasis
1
2009
252
0.020
 Why?
Chromosomes, Human, Pair 13
1
2008
41
0.020
 Why?
Serum Albumin
1
2008
62
0.020
 Why?
Polyethylene Glycols
1
2008
107
0.020
 Why?
Xenograft Model Antitumor Assays
1
2008
219
0.020
 Why?
Randomized Controlled Trials as Topic
1
2010
580
0.020
 Why?
Age Distribution
1
2007
198
0.020
 Why?
Antineoplastic Agents, Hormonal
1
2007
49
0.020
 Why?
Multigene Family
1
2006
54
0.020
 Why?
Recombinant Proteins
1
2008
570
0.020
 Why?
Cyclin D
1
2006
20
0.020
 Why?
Syndecans
1
2006
43
0.020
 Why?
RNA, Neoplasm
1
2006
54
0.020
 Why?
Cyclins
1
2006
54
0.020
 Why?
Proteoglycans
1
2006
96
0.020
 Why?
Leukemia, Myeloid, Acute
1
2007
192
0.020
 Why?
Brain
1
2013
1391
0.020
 Why?
Survivors
1
2006
137
0.020
 Why?
Pregnancy
1
2011
2637
0.010
 Why?
Lymphocyte Transfusion
1
2003
12
0.010
 Why?
Probability
1
2003
177
0.010
 Why?
Administration, Oral
1
2003
461
0.010
 Why?
Tissue Donors
1
2003
112
0.010
 Why?
Van Rhee's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (569) concept(s)
_
Co-Authors Expand Description
See all (60) people
_
Similar People Expand Description
See all (29) people
_
Same Department Expand Description
Search Department